Company Filing History:
1 out of 53 
1 out of 1,178 
Years Active: 2009-2010
Title: Zhlyuan Zhang: Innovator in Dipeptidyl Peptidase Inhibitors
Introduction
Zhlyuan Zhang is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dipeptidyl peptidase inhibitors. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Zhlyuan Zhang's latest patents focus on compounds, pharmaceutical compositions, kits, and methods for use with DPP-IV and other S9 proteases. The first patent details compounds of a specific formula, where the substituents are defined within the document. The second patent also addresses DPP-IV inhibitors, providing a formula with described substituents for pharmaceutical use.
Career Highlights
Throughout his career, Zhlyuan Zhang has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda San Diego, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to contribute to innovative research and development in the field.
Collaborations
Zhlyuan Zhang has collaborated with several professionals in his field, including Jun Feng and Stephen L Gwaltney. These collaborations have likely enhanced the quality and impact of his research.
Conclusion
Zhlyuan Zhang's contributions to the development of dipeptidyl peptidase inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.